Proportions of patients ultimately achieving major cytogenetic response by 12 months (12MMCyR)
| Time point, response . | n . | 12MMCyR, no. (%) . |
|---|---|---|
| Three months | ||
| Minor cytogenetic | 15 | 10 (67) |
| Complete hematologic response or hematologic failure | 42 | 3 (7) |
| Six months | ||
| Minor cytogenetic | 16 | 8 (50) |
| Complete hematologic response or hematologic failure | 39 | 1 (3) |
| Time point, response . | n . | 12MMCyR, no. (%) . |
|---|---|---|
| Three months | ||
| Minor cytogenetic | 15 | 10 (67) |
| Complete hematologic response or hematologic failure | 42 | 3 (7) |
| Six months | ||
| Minor cytogenetic | 16 | 8 (50) |
| Complete hematologic response or hematologic failure | 39 | 1 (3) |
Patients with no cytogenetic responses by 3 and 6 months were significantly less likely to reach 12MMCyR than patients with a minor cytogenetic response (P < .001 at both timepoints).